These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 15079851)

  • 61. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
    Ghanizadeh A
    J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?
    Gerlach M; Grünblatt E; Lange KW
    Atten Defic Hyperact Disord; 2013 Jun; 5(2):71-81. PubMed ID: 23605387
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Methylphenidate.
    St Dennis C; Synoground G
    J Sch Nurs; 1996 Feb; 12(1):5-8, 10-1. PubMed ID: 8696016
    [No Abstract]   [Full Text] [Related]  

  • 64. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.
    Preston RJ; Kollins SH; Swanson JM; Greenhill LL; Wigal T; Elliott GR; Vitiello B
    Cancer Lett; 2005 Dec; 230(2):292-4. PubMed ID: 16019134
    [No Abstract]   [Full Text] [Related]  

  • 66. [Apropos the National Board and Welfare's report on ADDH: some views on the treatment with central nervous system stimulants].
    Zetterström R
    Lakartidningen; 2002 Aug; 99(35):3435-6. PubMed ID: 12362770
    [No Abstract]   [Full Text] [Related]  

  • 67. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder.
    Bental B; Tirosh E
    J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
    Hollis CP; Thompson A
    Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Response to comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.
    El-Zein RA; Hay MJ; Lopez MS; Bondy ML; Morris DL; Legator MS; Abdel-Rahman SZ
    Cancer Lett; 2006 Jan; 231(1):146-8. PubMed ID: 16290920
    [No Abstract]   [Full Text] [Related]  

  • 70. An update on attention deficit disorder.
    Harv Ment Health Lett; 2004 May; 20(11):4-7. PubMed ID: 15153391
    [No Abstract]   [Full Text] [Related]  

  • 71. Abuse and toxicity of methylphenidate.
    Klein-Schwartz W
    Curr Opin Pediatr; 2002 Apr; 14(2):219-23. PubMed ID: 11981294
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children.
    Prescrire Int; 2004 Dec; 13(74):203-6. PubMed ID: 15612099
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combining methylphenidate and clonidine: a clinically sound medication option.
    Wilens TE; Spencer TJ; Swanson JM; Connor DF; Cantwell D
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):614-9; discussion 619-22. PubMed ID: 10230195
    [No Abstract]   [Full Text] [Related]  

  • 74. ADHD remains clinical challenge: data indicate need for closer follow-up of treated children.
    Golden W; Kinggard TE
    J Ark Med Soc; 2007 Jun; 103(12):297-8. PubMed ID: 17585709
    [No Abstract]   [Full Text] [Related]  

  • 75. Treatment of hyperactivity in children with pervasive developmental disorders.
    Scahill L; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):59-62. PubMed ID: 17284238
    [No Abstract]   [Full Text] [Related]  

  • 76. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.
    McGough JJ; Wigal SB; Abikoff H; Turnbow JM; Posner K; Moon E
    J Atten Disord; 2006 Feb; 9(3):476-85. PubMed ID: 16481664
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.
    Torres AR; Whitney J; Gonzalez-Heydrich J
    Epilepsy Behav; 2008 Feb; 12(2):217-33. PubMed ID: 18065271
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of methylphenidate in traumatic brain injury.
    Siddall OM
    Ann Pharmacother; 2005; 39(7-8):1309-13. PubMed ID: 15914519
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An unlikely vice: Ritalin.
    Vishio J
    Adv Nurse Pract; 2001 Feb; 9(2):60. PubMed ID: 12416056
    [No Abstract]   [Full Text] [Related]  

  • 80. Stimulant medications: how to minimize their reinforcing effects?
    Volkow ND
    Am J Psychiatry; 2006 Mar; 163(3):359-61. PubMed ID: 16513852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.